Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145 | -52.0% | 26,670 | -40.0% | 0.01% | -46.2% |
| Q2 2023 | $302 | +134.1% | 44,470 | +72.2% | 0.01% | +116.7% |
| Q1 2023 | $129 | +2.4% | 25,820 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $126 | -100.0% | 25,820 | +47.7% | 0.01% | -53.3% |
| Q3 2022 | $252,000 | +14.5% | 17,482 | +20.0% | 0.02% | -11.8% |
| Q2 2022 | $220,000 | +76.0% | 14,564 | +38.5% | 0.02% | +112.5% |
| Q1 2022 | $125,000 | – | 10,514 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |